Cargando…

Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice

BACKGROUND: Current medical treatments for endometriosis are very limited. Progestin and selective progesterone receptor modulators (SPRM) are developed but their efficacy, safety, mechanism and recurrence in endometriosis are not fully studied. METHODS: In order to compare therapeutic, side effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Bo, Wu, Ling, Xu, Hui, Cheung, Chun Wai, Fung, Wen Ying, Wong, Sze Wai, Wang, Chi Chiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883298/ https://www.ncbi.nlm.nih.gov/pubmed/29615065 http://dx.doi.org/10.1186/s12958-018-0347-9

Ejemplares similares

Effects of Progestin on Modulation of the Expression of Biomarkers in Endometriosis
por: Matasariu, Daniela Roxana, et al.
Publicado: (2023)

Progestins in the symptomatic management of endometriosis: a meta-analysis on their effectiveness and safety
por: Mitchell, Jon-Benay, et al.
Publicado: (2022)

Plasma Levels of Progestin During Absorption of Progesterone Pellets in Mice
por: Forbes, Thomas R., et al.
Publicado: (1958)

Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions
por: Houshdaran, Sahar, et al.
Publicado: (2020)

Use of progesterone and progestin analogs for inhibition of preterm birth and other uterine contractility disorders
por: Garfield, R.E., et al.
Publicado: (2012)

Effects of hormonal contraceptive phase and progestin generation on stress-induced cortisol and progesterone release
por: Herrera, Alexandra Ycaza, et al.
Publicado: (2019)

Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis
por: Asi, Noor, et al.
Publicado: (2016)

Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells
por: Willibald, Marina, et al.
Publicado: (2017)

Melatonin in Endometriosis: Mechanistic Understanding and Clinical Insight
por: Li, Yiran, et al.
Publicado: (2022)

Tolerability of endometriosis medical treatment: a comparison between combined hormonal contraceptives and progestins
por: da Costa Pinheiro, Denise Joffily Pereira, et al.
Publicado: (2023)

Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report
por: Liang, Angela L., et al.
Publicado: (2021)

Live-Birth Outcomes and Congenital Malformations After Progestin-Primed Ovarian Stimulation in Maternal Endometriosis
por: Liang, Zhou, et al.
Publicado: (2020)

Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma
por: Cheung, Phyllis F.Y., et al.
Publicado: (2016)

Effects of Natural Progesterone and Synthetic Progestin on Germ Layer Gene Expression in a Human Embryoid Body Model
por: Kim, Yoon Young, et al.
Publicado: (2020)

Metabolomics analysis of follicular fluid in ovarian endometriosis women receiving progestin-primed ovary stimulation protocol for in vitro fertilization
por: Guo, Haiyan, et al.
Publicado: (2023)

90 YEARS OF PROGESTERONE: Selective progesterone receptor modulators in gynaecological therapies
por: Critchley, H O D, et al.
Publicado: (2020)

The cost-effective, but forgotten, medical endometriosis therapy: a prospective, quasi-randomized study on progestin therapy
por: Cezar, TC, et al.
Publicado: (2018)

Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols
por: Mathieu d’Argent, Emmanuelle, et al.
Publicado: (2020)

Role of suppression of endometriosis with progestins before IVF-ET: a non-inferiority randomized controlled trial
por: Khalifa, Eissa, et al.
Publicado: (2021)

Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha
por: Perkins, Meghan S., et al.
Publicado: (2022)

MicroRNAs and Progesterone Receptor Signaling in Endometriosis Pathophysiology
por: Nothnick, Warren B.
Publicado: (2022)

Progesterone Resistance in Endometriosis: Current Evidence and Putative Mechanisms
por: Zhang, Ping, et al.
Publicado: (2023)

MicroRNAs in Endometriosis: Insights into Inflammation and Progesterone Resistance
por: Hon, Jing-Xian, et al.
Publicado: (2023)

Pharmacokinetics and Safety of the Novel Selective Progesterone Receptor Modulator Vilaprisan in Participants With Renal Impairment
por: Schultze‐Mosgau, Marcus‐Hillert, et al.
Publicado: (2020)

Pharmacokinetics and Safety of the Selective Progesterone Receptor Modulator Vilaprisan in Chinese Healthy Postmenopausal Women
por: Liu, Hongzhong, et al.
Publicado: (2020)

Progestin and Nuclear Progestin Receptor Are Essential for Upregulation of Metalloproteinase in Zebrafish Preovulatory Follicles
por: Liu, Dong Teng, et al.
Publicado: (2018)

Phosphorylation of human progesterone receptors by MAPKs mediates transcriptional synergy between progestins and MEKK1 in human breast cancer cells
por: Lange, CA, et al.
Publicado: (2000)

Progesterone receptors – animal models and cell signalling in breast cancer: Implications for breast cancer of inclusion of progestins in hormone replacement therapies
por: Schairer, Catherine
Publicado: (2002)

Progesterone's Effects on Cognitive Performance of Male Mice Are Independent of Progestin Receptors but Relate to Increases in GABA(A) Activity in the Hippocampus and Cortex
por: Frye, Cheryl A., et al.
Publicado: (2021)

High Levels of Progesterone Receptor B in MCF-7 Cells Enable Radical Anti-Tumoral and Anti-Estrogenic Effect of Progestin
por: Bajalovic, Natasa, et al.
Publicado: (2022)

Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis?
por: Marquardt, Ryan M., et al.
Publicado: (2019)

Recurrence of cervical cancer and its resistance to progestin therapy in a mouse model
por: Mehta, Fabiola F, et al.
Publicado: (2016)

Hypoluteoidism in a dog associated with recurrent mammary fibroadenoma stimulated by progestin therapy
por: Zedda, Maria Teresa, et al.
Publicado: (2017)

Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility
por: Islam, Md Soriful, et al.
Publicado: (2020)

Progestins and mammary cancer induction.
por: Coezy, E., et al.
Publicado: (1973)

Efficacy of Different Progestins in Women With Advanced Endometriosis Undergoing Controlled Ovarian Hyperstimulation for in vitro Fertilization-A Single-Center Non-inferiority Randomized Controlled Trial
por: Guo, Haiyan, et al.
Publicado: (2020)

Notch-1 Signaling Activation and Progesterone Receptor Expression in Ectopic Lesions of Women With Endometriosis
por: Brown, Dustin M, et al.
Publicado: (2018)

Two unrelated putative membrane-bound progestin receptors, progesterone membrane receptor component 1 (PGMRC1) and membrane progestin receptor (mPR) beta, are expressed in the rainbow trout oocyte and exhibit similar ovarian expression patterns
por: Mourot, Brigitte, et al.
Publicado: (2006)

The Progestin Revolution: progestins are arising as the dominant players in the tight interlink between contraceptives and bleeding control
por: Shoupe, Donna
Publicado: (2021)

Efficacy of Low-Dose Estrogen–Progestins and Progestins in Japanese Women with Dysmenorrhea: A Systematic Review and Network Meta-analysis
por: Iwata, Masaru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pts5jdoj4l44dqljqu0r2ppd2p